# FDA Inspection 1147450 - Haematologic Technologies, LLC dba Prolytix - July 30, 2021

Source: https://www.globalkeysolutions.net/records/fda_inspections/haematologic-technologies-llc-dba-prolytix/dd1f1270-2289-4dff-acb7-884da6a6a1cc
Source feed: FDA_Inspections

> FDA Inspection 1147450 for Haematologic Technologies, LLC dba Prolytix on July 30, 2021. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1147450
- Company Name: Haematologic Technologies, LLC dba Prolytix
- Inspection Date: 2021-07-30
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1258523 - 2025-01-06](https://www.globalkeysolutions.net/records/fda_inspections/haematologic-technologies-llc-dba-prolytix/2bd126ff-88fd-4f0c-b960-123053dbc85c)
- [FDA Inspection 1098078 - 2019-06-27](https://www.globalkeysolutions.net/records/fda_inspections/haematologic-technologies-llc-dba-prolytix/50ca8d3d-8097-4872-aed7-441384aec950)
- [FDA Inspection 1027695 - 2017-07-28](https://www.globalkeysolutions.net/records/fda_inspections/haematologic-technologies-llc-dba-prolytix/9b2964a1-23ba-4602-8250-6d224de178bd)
- [FDA Inspection 1013147 - 2017-05-11](https://www.globalkeysolutions.net/records/fda_inspections/haematologic-technologies-llc-dba-prolytix/c6e6dd3e-5093-458a-9a69-6b09b1f005a4)
- [FDA Inspection 887848 - 2014-06-26](https://www.globalkeysolutions.net/records/fda_inspections/haematologic-technologies-llc-dba-prolytix/4bdaa7a4-e966-4a70-ae91-a3f0f5e7a337)

Company: https://www.globalkeysolutions.net/companies/haematologic-technologies-llc-dba-prolytix/03297ca5-f207-401a-8202-1b343903beed

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d